Recombinant Dictyostelium discoideum Probable serine/threonine-protein kinase roco11 (roco11), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during the production process. If you require a particular tag, please inform us, and we will prioritize its development.
Synonyms
roco11; DDB_G0268636; Probable serine/threonine-protein kinase roco11; EC 2.7.11.1; Ras of complex proteins and C-terminal of roc 11
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Dictyostelium discoideum (Slime mold)
Target Names
roco11
Uniprot No.

Q&A

What is the evolutionary history of the roco11 gene in Dictyostelium species?

Phylogenetic analysis across four slime mold species reveals that Roco11 evolved relatively recently in evolutionary history through duplication of an ancestral roco4 gene. This duplication event occurred after the split between Dictyostelium discoideum and Dictyostelium purpureum, estimated to have happened approximately 300 million years ago. This contrasts with most other roco genes, which were present in the common ancestor of D. discoideum and Polysphondylium pallidum (more than 600 million years ago). The presence of roco11 exclusively in D. discoideum among the studied species confirms its relatively recent emergence in slime mold evolution .

What phenotypic changes are observed in roco11-null Dictyostelium cells?

Knockout studies have demonstrated that cells lacking Roco11 form characteristically larger fruiting bodies compared to wild-type cells. Interestingly, this occurs without initially forming larger aggregation centers, suggesting that the effect manifests during later developmental stages. This phenotype aligns with expression data showing that Roco11 expression increases during the multicellular stages of development, particularly after the aggregation phase. The specific molecular mechanisms by which Roco11 regulates fruiting body size remain an active area of investigation .

What purification strategies are most suitable for isolating recombinant roco11 kinase domain?

Purification of the recombinant roco11 kinase domain requires a multi-step approach to ensure high purity and retention of enzymatic activity. Initial capture typically employs immobilized metal affinity chromatography (IMAC) using histidine tags, followed by ion exchange chromatography to remove contaminants and degradation products. For achieving high purity suitable for structural studies, size exclusion chromatography as a final polishing step is recommended. Throughout the purification process, maintaining protein stability is critical; buffers containing 20-50 mM Tris-HCl (pH 7.5-8.0), 150-300 mM NaCl, 1-5 mM DTT or TCEP, and 5-10% glycerol have proven effective in preserving kinase activity. Additionally, including ATP analogs or kinase inhibitors during purification can enhance stability by locking the kinase in a specific conformational state, particularly useful when preparing samples for structural analysis .

How can researchers effectively measure the kinase activity of recombinant roco11?

Measuring kinase activity of recombinant roco11 requires selecting appropriate substrates and assay conditions. Based on its classification as a serine/threonine kinase, researchers should initially screen generic substrates such as myelin basic protein, histone H1, or casein to establish baseline activity. For more specific activity profiling, synthetic peptide arrays containing various consensus phosphorylation motifs can help identify preferred substrate sequences. Quantitative kinase assays can utilize either radioactive methods (γ-32P-ATP incorporation) for highest sensitivity or non-radioactive approaches (coupled enzymatic assays or phospho-specific antibodies) for convenience. Reaction conditions should be optimized for pH (typically 7.0-7.5), divalent cation concentration (Mg2+ or Mn2+), and ATP concentration. When comparing wild-type to mutant variants or analyzing inhibitor effects, establishing initial velocity conditions is essential for accurate kinetic parameter determination. Controls should include kinase-dead mutants (typically with mutations in the catalytic lysine residue) to distinguish between autophosphorylation and substrate phosphorylation .

How does the structural comparison between roco11 and LRRK2 inform therapeutic approaches for Parkinson's disease?

The structural comparison between Dictyostelium roco11 and human LRRK2 presents valuable opportunities for Parkinson's disease therapeutic development. Both proteins belong to the Roco family and share the characteristic Roc-COR-kinase domain arrangement, making roco11 a potential model for understanding LRRK2 function. Analysis of the conserved structural elements across these proteins reveals potential druggable pockets and regulatory mechanisms. Specifically, research should focus on: (1) comparative analysis of the GTPase domains, as GTP binding regulates kinase activity in LRRK2; (2) examination of the intramolecular interactions between the Roc and kinase domains that may represent targets for allosteric modulators; and (3) identification of pathogenic-equivalent mutations in roco11 that mirror those found in familial Parkinson's disease. When conducting such comparative studies, researchers should employ molecular dynamics simulations alongside experimental structural data to identify potential conformational changes induced by mutations or ligand binding. This approach can reveal novel interaction sites that might not be apparent in static structural models .

What techniques are most effective for studying roco11 protein-protein interactions in the context of developmental signaling pathways?

For investigating roco11 protein-protein interactions in developmental signaling contexts, researchers should employ complementary approaches to capture both stable and transient interactions. Proximity-dependent biotin labeling methods (BioID or TurboID) are particularly valuable for identifying the spatial interactome of roco11 during Dictyostelium development. These approaches can be complemented with co-immunoprecipitation followed by mass spectrometry to validate specific interaction partners. For temporal resolution, researchers should implement stage-specific protein isolation using inducible expression systems or developmental time-course sampling. When analyzing interaction data, bioinformatic clustering based on functional categories can reveal whether roco11 participates in distinct protein complexes during different developmental stages. Additionally, researchers should perform domain-specific interaction mapping to determine whether the LRR, Roc, COR, or kinase domains mediate different sets of protein interactions. Cross-validation of key interactions using fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) in living Dictyostelium cells during development provides spatial context to the interactions identified through biochemical methods .

How can phosphoproteomic analysis be applied to identify downstream targets of roco11 kinase activity?

Phosphoproteomic analysis offers a powerful approach for identifying downstream targets of roco11 kinase activity in Dictyostelium. A comprehensive experimental design should include comparison between wild-type and roco11-null cells, as well as cells expressing kinase-dead mutants or constitutively active variants. Sample collection should occur at multiple developmental timepoints, particularly during the transition from mound to fruiting body formation where roco11 function appears most critical. For phosphopeptide enrichment, researchers should employ a combination of techniques including titanium dioxide (TiO2) chromatography, immobilized metal affinity chromatography (IMAC), and phosphotyrosine-specific antibodies to ensure comprehensive coverage of the phosphoproteome. Statistical analysis should prioritize phosphosites that show consistent changes across biological replicates and correlate with developmental phenotypes. To distinguish direct from indirect targets, researchers should complement global phosphoproteomics with in vitro kinase assays using recombinant roco11 and candidate substrates. Motif analysis of significantly altered phosphosites can reveal consensus sequences that may aid in identifying additional substrates not detected in the initial screen. Integration of phosphoproteomic data with transcriptomic and interactomic datasets can place roco11 within specific signaling networks active during Dictyostelium development .

Experimental ApproachAdvantagesLimitationsBest For
Global phosphoproteomicsUnbiased discovery of all phosphorylation changesCannot distinguish direct vs. indirect targetsSystem-wide effects of roco11
Targeted phosphoproteomicsHigher sensitivity for specific proteinsRequires prior knowledge of targetsValidation of candidate substrates
In vitro kinase assaysConfirms direct phosphorylationMay not reflect in vivo conditionsDetermining substrate specificity
Phospho-specific antibodiesTemporal and spatial resolutionLimited to known phosphositesTracking specific phosphorylation events
Phosphomimetic mutationsTests functional relevanceMay not fully mimic phosphorylationPhenotypic validation of key sites

How does the structural and functional divergence between roco11 and roco4 inform our understanding of protein evolution after gene duplication?

The evolutionary relationship between roco11 and roco4 provides an excellent model for studying functional divergence following gene duplication. Comparative analysis reveals that while roco11 retained the core Roc-COR-kinase domains from its roco4 ancestor, it lost the WD40 repeats present in all Roco4 proteins. This structural modification likely contributed to functional specialization, as evidenced by their distinct developmental phenotypes: roco4-null cells show defects in stalk formation and cellulose production, while roco11-null cells form larger fruiting bodies. To fully characterize this divergence, researchers should conduct detailed domain-by-domain comparison of sequence conservation rates, which can identify regions under positive or purifying selection. Additionally, comparing the interactomes of roco4 and roco11 may reveal how protein-protein interaction networks evolved following duplication. Expression pattern analysis across developmental stages and cell types can further illuminate how regulatory elements diverged to create distinct spatiotemporal expression profiles. For mechanistic insights, researchers should perform domain-swapping experiments between roco4 and roco11, particularly exchanging the N-terminal regions or the missing WD40 domain, to determine which structural elements are responsible for their specialized functions .

What insights about Roco protein evolution can be gained by comparing the Dictyostelium roco11 with Roco proteins in other species?

Comparative analysis of Dictyostelium roco11 with Roco proteins across species provides valuable insights into the evolution of this protein family. Since roco11 resulted from a relatively recent gene duplication (less than 300 million years ago) and is found only in Dictyostelium discoideum, it represents an excellent case study in protein neofunctionalization. Cross-species comparison should include analysis of selection pressures on different domains, with particular attention to the conserved Roc-COR-kinase core versus species-specific regions. Researchers should utilize phylogenetic inference methods that can detect domain shuffling events, as these appear common in Roco protein evolution. When analyzing human LRRK1/2 in comparison to Dictyostelium roco11, focus should be placed on identifying functionally equivalent residues, particularly those in the kinase domain that may be involved in substrate recognition. Structural modeling of the kinase domains across species can reveal conservation of catalytic mechanisms despite sequence divergence. Additionally, comparative analysis of interacting partners across species may identify evolutionarily conserved signaling networks versus species-specific pathways. This multi-faceted approach can reveal how Roco proteins have been repurposed throughout evolution while maintaining certain core functions, providing insights into both fundamental evolutionary processes and potential translational applications for human disease research .

What strategies can overcome common challenges in expressing and purifying active recombinant roco11?

Researchers frequently encounter challenges when expressing and purifying active recombinant roco11, particularly related to protein solubility, stability, and enzymatic activity. To address solubility issues, consider expressing individual domains separately rather than the full-length protein, as the multi-domain structure often leads to folding difficulties. The kinase domain (residues ~1100-1400, depending on construct design) can typically be expressed with higher yield than the complete protein. For bacterial expression, lowering the induction temperature to 16-18°C and using a low IPTG concentration (0.1-0.2 mM) can significantly improve proper folding. If inclusion body formation persists, switching to insect cell or Dictyostelium expression systems often yields properly folded protein. For purification, stability can be enhanced by including 5-10% glycerol, 1 mM ATP, and 2-5 mM MgCl₂ in all buffers. If aggregation occurs during concentration, adding non-ionic detergents (0.01-0.05% Triton X-100) or arginine (50-200 mM) can maintain monodispersity. For activity assays, prepare fresh protein samples whenever possible, as freeze-thaw cycles significantly reduce kinase activity. If long-term storage is necessary, flash-freeze small aliquots in liquid nitrogen and store at -80°C with cryoprotectants such as 10% glycerol .

How can researchers address the challenge of specificity when developing antibodies against roco11?

Developing specific antibodies against roco11 presents significant challenges due to its sequence similarity with other Roco family members, particularly Roco4 and QkgA which share 60-80% identity in several domains. To generate highly specific antibodies, researchers should carefully select immunogenic regions that are unique to roco11. The optimal approach involves bioinformatic analysis to identify roco11-specific sequences, particularly in the regions flanking the conserved domains or in loop regions that differ from other Roco proteins. Synthetic peptides (15-20 amino acids) from these unique regions serve as effective antigens, with conjugation to carrier proteins like KLH or BSA to enhance immunogenicity. When raising antibodies, a multi-epitope strategy targeting 2-3 distinct regions unique to roco11 provides redundancy and increases success probability. For validation, researchers must perform extensive cross-reactivity testing against recombinant Roco4 and QkgA proteins, as well as using lysates from roco11-null cells as negative controls. If traditional antibody approaches prove insufficient, alternative protein recognition reagents such as nanobodies or aptamers may offer improved specificity. For phosphorylation site-specific antibodies, phosphopeptides corresponding to putative roco11 autophosphorylation sites should be designed with sufficient flanking sequences to ensure recognition context .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.